Evidence map›Paper›PMID 29531066›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2018

Cross-resistance to dicamba, 2,4-D, and fluroxypyr in

Sherry LeClere, Chenxi Wu, Philip Westra, R Douglas Sammons

Erratum issuedOpen access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
16.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Article
  3. Creation of new rice germplasm with cross-resistance to auxin herbicides picloram and dicamba by genome editing of OsAFB4.TAG. Theoretical and applied genetics. Theoretische und angewandte Genetik · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. An in-frame deletion mutation in the degron tail of auxin coreceptorProceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Sherry LeClereAgricultural Productivity Innovations Division, Monsanto, Chesterfield, MO 63017; sherry.leclere@monsanto.com.
Chenxi WuAgricultural Productivity Innovations Division, Monsanto, Chesterfield, MO 63017.
Philip WestraDepartment of Bioagricultural Sciences and Pest Management, College of Agricultural Sciences, Colorado State University, Fort Collins, CO 80523-1177.
R Douglas SammonsAgricultural Productivity Innovations Division, Monsanto, Chesterfield, MO 63017.
Monsanto (United States) · USColorado State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The understanding and mitigation of the appearance of herbicide-resistant weeds have come to the forefront of study in the past decade, as the number of weed species that are resistant to one or more herbicide modes of action is on the increase. Historically, weed resistance to auxin herbicides has been rare, but examples, such as

Indexed as

Mutation2,4-Dichlorophenoxyacetic AcidAcetatesArabidopsisBassia scopariaDicambaHerbicide ResistanceHerbicidesIndoleacetic AcidsPlant ProteinsPlant WeedsPyridines2,4-Dichlorophenoxyacetic Acid4,5-amino-3,5-dichloro-6-fluoro-2-pyridinyloxyacetic acidAcetatesDicambaHerbicidesindoleacetic acidIndoleacetic AcidsPlant ProteinsPyridinesauxinherbicideKsIAA16KsTIR1weed resistance

Identifiers

PMID29531066
PMCPMC5879655
OpenAlexW2793816088

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.